Date: Sunday, June 3, 2018
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall 4EF
Objective: The aim of this study is to identify factors associated with increased resource use and total hospital cost after liver transplantation (LT).
Methods: A study of liver transplantation patients undergoing surgery between January 2008 to December 2013 was performed. Main end points were LOS, ICU LOS, days on the ventilator, total hospital costs (THC), service area costs
Results: 191 patients undergoing LT were included in the analysis. Creatinine and blood transfusion were significantly associated with prolonged LOS, ICU LOS and days on the ventilator. Multivariable analysis of predictors of THC demonstrated creatinine as a strong pre-operative factor. Creatinine was also a significant predictor of OR, ICU, pharmacy, in-patient (floor), diagnostics, and ancillary services cost. After controlling for intraoperative factors such as operative time and blood transfusions we found that transfusions were the strongest independent predictors of total cost. Patients receiving less than 5 units of PRBCs had a median LOS of 7 days. ICU LOS doubled and ICU total cost increased by 50% if patients required more than 5 transfusions of PRBCs.
Conclusions: Elevated serum creatinine and blood transfusions are the most critical determinants of increased resource utilization and hospital expenditure in liver transplantation.
CITATION INFORMATION: Garcia C., Dugan A., Davenport D., Gedaly R. Blood Transfusion is a Critical Determinant of Resource Utilization and Total Hospital Cost in Liver Transplantation Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Garcia C, Dugan A, Davenport D, Gedaly R. Blood Transfusion is a Critical Determinant of Resource Utilization and Total Hospital Cost in Liver Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/blood-transfusion-is-a-critical-determinant-of-resource-utilization-and-total-hospital-cost-in-liver-transplantation/. Accessed July 8, 2020.
« Back to 2018 American Transplant Congress